Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers of diagnostic products, vaccines, finished pharmaceutical products and active pharmaceutical ingredients 1
Priorities for Product Development and Procurement Reproductive Health Mr. Morten Sorensen, Deputy Chief, Procurement Specialist PSB, UNFPA 2
Reproductive and Maternal health The Commission estimated that, if more widely accessed and properly used, these commodities could save the lives of over 6 million women and children. This would catalyze and accelerate the reduction in deaths for women and children. http://www.everywomaneverychild.org/resources /un-commission-on-life-saving-commodities#sthash.1lucbicm.dpuf Joint UNICEF, UNFPA & WHO MEETING with manufacturers and suppliers 3
Priorities for Product Development and Procurement Reproductive and Maternal health UNCoLSC (UN Commission on Life-Saving Commodities) Female condoms Implantable contraceptives Emergency contraception Oxytocin Misoprostol Magnesium Sulphate Other Long Acting Reversible contraceptives - injectable Joint UNICEF, UNFPA & WHO MEETING with manufacturers and suppliers 4
Reproductive and Maternal health WHO Prequalified RH medicines extracted from WHO PQT INN Formulation and strength Applicant Packaging Reference Date of PQ Etonogestrel Implants 68mg NV Organon Blister pack (polyethyleneterephtalate glycol sealed with coated paper) 1 implant (in the cannula of a disposable sterile applicator) Etonogestrel Implant (X-ray detectable) 68mg NV Organon Blister pack (PETG sealed with HDPE lidding); 1 implant (preloaded in the stainless steel needle of a ready-to-use, disposable, sterile applicator) RH020 (a) RH036 (a) 2010-Jun-02 2013-May-23 Levonorgestrel Coated tablets 30µg Bayer Pharma AG PVC/Alu blister 3 x 35 RH002 (a) 2009-May-26 Levonorgestrel Implants (without inserter) 2 rods each with 75mg Bayer Oy PE bag (manufactured from spunbonded PE film and a PET/PE film), 2 rods in one package RH017 (a) 2009-Sep-23 Levonorgestrel Tablets 0.75mg Gedeon Richter Plc Al/PVC blister 1 x 2 RH024 (a) 2010-Aug-20 Levonorgestrel Tablets 1.5mg Famy Care Ltd Al/PVC/PVDC blister 1 x 1 RH031 2013-Oct-21 Levonorgestrel Tablets 750µg Famy Care Ltd PVC/PVdC/Alu blister 1x2 RH032 2013-Jun-14 Levonorgestrel Tablets 0.75mg Cipla Ltd Al/PVC/PE/PVDC blister 1 x 2 RH040 2014-Apr-08 Medroxyprogesterone acetate Suspension for injection 150mg/ml Pfizer Glass vial 1ml RH018 (a) 2010-Aug-20 Misoprostol Tablets 200µg Linepharma International Alu/alu strip 1x4, 15x4, 30x4 EMA Art 58 Misoprostol Tablets 200µg Cipla Ltd Alu/Alu blister 1 x 4, 7 x 4, 15 x 4 RH039 2014-Apr-08 Norethisterone enantate Injection 200mg/ml Bayer Schering Pharma AG Glass ampoule 1ml (100 per carton) RH022 (a) 2011-Oct-05 Joint UNICEF, UNFPA & WHO MEETING with manufacturers and suppliers 5
Reproductive and Maternal health Injectable contraception Depo Medroxyprogesterone acetate (DMPA) One WHO PQed Norethisterone enantate One WHO PQed Innovator products - non-radioopaque, radioopaque Generic implants none WHO PQed Joint UNICEF, UNFPA & WHO MEETING with manufacturers and suppliers 6
Reproductive and Maternal health Implants Innovator products - non-radioopaque, radioopaque Generic implants none WHO PQed Joint UNICEF, UNFPA & WHO MEETING with manufacturers and suppliers 7
Reproductive and Maternal health Procurement Volumes of hormonal contraceptives 2010-2012 DFID, IPPF, KfW, MSI, PSI, UNFPA, USAID Product 2010 2011 2012 Oral Contraceptive pills (cycles) 161,882,534 167,382,470 159,526,922 Emergency contraceptive pills (per treatment) 3,262,617 3,500,948 3,368,120 Injectables (vials) 63,334,037 72,406,531 76,733,437 Implants (set) 1,561,545 2,494,956 4,094,739 Sources: http://www.unfpa.org/webdav/site/global/shared/documents/publications/2011/final%20donor%20support%202010-2.pdf http://www.unfpa.org/webdav/site/global/shared/documents/publications/2012/external%20procurement%20support%20report%202012.pdf Joint UNICEF, UNFPA & WHO MEETING with manufacturers and suppliers 8
Reproductive and Maternal health Oxytocin CHALLENGES: Stability Varying storage instructions on the products - Store below 25 to 2-8 C Reality stored in normal shelves, no temperature control and often at temperatures above 25 C NEEDS: Heat stable Formulations under studies different organisations Sublingual tablet Pharmacokinetic studies Inhaled oxytocin studies are on-going Joint UNICEF, UNFPA & WHO MEETING with manufacturers and suppliers 9
Reproductive and Maternal health Magnesium Sulphate AND Misoprostol Mg Sulphate None is WHO Pqed Misoprostol Two WHO PQd One SRA approved PPH not included in indications off-label Some country programmes resistance to use the product as an off-label Joint UNICEF, UNFPA & WHO MEETING with manufacturers and suppliers 10
Reproductive and Maternal health Procurement values (USD) UNFPA Oxytocin, Mag Sulphate, Misoprostol Name of product 2011 2012 2013 Magnesium Sulphate 486,240.00 1,070,148.00 679,276.00 Misoprostol 39,046.00 14,500.00 634,433.00 Oxytocin 565,000.00 746,420.00 684,980.00 Joint UNICEF, UNFPA & WHO MEETING with manufacturers and suppliers 11
UNFPA AccessRH Inventory Procurement Please visit: www.myaccessrh.org 12
AccessRH: Partners in Reproductive Health Supplies Better Planning Safe and Effective Products Easy Ordering
AccessRH Online Product Catalog www.myaccessrh.org/products
AccessRH Online Product Catalog 40 18 4 400+ 200+ Contraceptives Reproductive health kits Midwifery and Fistula repair kits Medical equipment items Pharmaceutical products
Wait time for condoms from inventory is about 15 weeks less than from production 22 20 18 16 14 12 10 8 6 4 2 - wait time reduction Production Inventory 2011 Q1 2011 Q3 2012 Q1 2012 Q3
17
Contraceptive Distribution Latest statistics 2013 18
Pharmaceuticals Distribution Latest statistics 2013 19
On-going and new initiatives > Greening Health Care Procurement including pharmaceutical procurement > On-going ERP > On-going Pre-qual > On-going lab training (onsite), lab workshops, procurement capacity building etc. > Capacity building regulatory authorities 20
THANK YOU 21